uPAR antagonists (Boehringer Mannheim)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameuPAR antagonists (Boehringer Mannheim)
Drug Alias Nameurokinase-type plasminogen-activator receptor antagonists (Boehringer Mannheim)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activators inhibitors
TargetsPlasminogen activators
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Mannheim Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Mannheim Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A